Critical Equipment for Dosing Administration and Monitoring |
INOMAX® is a vasodilator, which, in conjunction with ventilatory support and other appropriate agents, is indicated for the treatment of term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, where it improves oxygenation and reduces the need for extracorporeal membrane oxygenation.
INOMAX Important Safety Information (ISI)
INOMAX should not be used in the treatment of neonates known to be dependent on right-to-left shunting of blood
Delivery Systems
With INOMAX®, you receive all the advanced-technology equipment needed to accurately administer and monitor the delivery of INOMAX. This includes:
- INOmax® DS and INOvent® drug delivery technology is equipped with safety sensors for monitoring nitric oxide (NO), oxygen (O2), and nitrogen dioxide (NO2) for safe administration and compatibility with invasive mechanical ventilation methods and noninvasive respiratory strategies, including CPAP and nasal cannula*
- INOcal® calibration gases and kits for precise system calibration and accurate administration of prescribed INOMAX dosage
- INOmeter™ for recording the exact treatment times for accurate billing and reimbursement
- DISPOSABLES including unlimited supply of adaptors, tubing, connectors, and cartridges
*Please see sales representative to find out if your ventilator is compatible with INOvent or INOmax DS.
To learn more or to schedule an appointment with one of your INOMAX representatives, medical science liaisons, or service technicians, please call 1-877-566-9466. For additional information, please Contact Us.
References
1. Angus DC, Clermont G, Watson RS, Linde-Zwirble WT, Clark RH, Roberts MS. Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. Pediatrics. 2003;112(6 Pt 1):1351-1360.
4. Lipkin PH, Davidson D, Spivak L, Straube R, Rhines J, Chang CT. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J Pediatr. 2002:140(3):306-310.
7. INOMAX® [package insert]. Clinton, NJ: Ikaria Holdings; 2009.